Sonoma Pharmaceuticals

$7.15
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.34 (+4.99%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SNOA and other stocks, options, and ETFs commission-free!

About SNOA

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Woodstock, GA. The listed name for SNOA is Sonoma Pharmaceuticals, Inc. Common Stock.

CEO

Amy M. Trombly

Employees

298

Headquarters

Woodstock, Georgia

Founded

1999

Market Cap

17.23M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

38.86K

High Today

$7.30

Low Today

$6.65

Open Price

$6.80

Volume

47.93K

52 Week High

$19.60

52 Week Low

$3.55

SNOA Earnings

-$2.45

-$1.61

-$0.76

$0.08

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

-$0.31 per share